BioLife Solutions (BLFS) Q2 2026 earnings — TrendMatrix coverage
BEAT+40.5% vs estimateEPS $0.08 vs $0.06 est
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Event detail · Q2 2026
Key numbers
- Adjusted EPS
- $0.08
- Estimate
- $0.06
- Surprise
- +40.5%
- Revenue (period 2026-06-30)
- $28.5M
Revenue source: xbrl.
Report record · Q2 2026
How the report landed
BioLife Solutions (BLFS) beat the $0.06 estimate with adjusted EPS of $0.08 — a large 40.5% upside surprise.